World

Citiation Rankings

Eli Lilly and Company Scientists Citation Rankings 2024

Citation Rankings is a unique service offered only by “AD Scientific Index”. This is a ranking system derived from the Citation index in order to show the impact of the scientist in publishing scientific articles of value.  Click for "last 6 years citation index" Click for individual or institutional registration.

search
×
Total 190 scientist, 1 country, 1 institution
David A Collier
David A Collier i
Eli Lilly and Company
Eli Lilly and Company
Social Sciences / Psychology
psychosis
neurodegeneration
bioinformatics
genomics
drug development
Citation Rankings
University / Institution:
# 1
Country:
# 2,004
Region:
# 2,162
World:
# 4,147
Citation
Total:
80,727
Last 6 Year:
27,588
Last 6 Year/Total:
0.342
i10 Index
Total:
436
Last 6 Year:
247
Last 6 Year/Total:
0.567
H-Index
Total:
122
Last 6 Year:
62
Last 6 Year/Total:
0.508
Martin Citron
Martin Citron
Eli Lilly and Company
Eli Lilly and Company
Others
Alzheimer's disease
Neurodegeneration
Drug discovery
Citation Rankings
University / Institution:
# 2
Country:
# 7,540
Region:
# 8,171
World:
# 15,841
Citation
Total:
35,642
Last 6 Year:
6,111
Last 6 Year/Total:
0.171
i10 Index
Total:
82
Last 6 Year:
61
Last 6 Year/Total:
0.744
H-Index
Total:
60
Last 6 Year:
37
Last 6 Year/Total:
0.617
David R Ferry
David R Ferry
Eli Lilly and Company
Eli Lilly and Company
Others
GI cancer
translational research
lung cancer
phase 1 trials
Citation Rankings
University / Institution:
# 3
Country:
# 11,797
Region:
# 12,842
World:
# 25,501
Citation
Total:
26,276
Last 6 Year:
8,585
Last 6 Year/Total:
0.327
i10 Index
Total:
175
Last 6 Year:
84
Last 6 Year/Total:
0.480
H-Index
Total:
73
Last 6 Year:
40
Last 6 Year/Total:
0.548
Christian C Felder
Christian C Felder
Eli Lilly and Company
Eli Lilly and Company
Medical and Health Sciences / Neuroscience
Neuroscience & Drug Discovery
Citation Rankings
University / Institution:
# 4
Country:
# 12,708
Region:
# 13,843
World:
# 27,592
Citation
Total:
24,931
Last 6 Year:
4,992
Last 6 Year/Total:
0.200
i10 Index
Total:
141
Last 6 Year:
86
Last 6 Year/Total:
0.610
H-Index
Total:
75
Last 6 Year:
33
Last 6 Year/Total:
0.440
Stephen Hall
Stephen Hall
Eli Lilly and Company
Eli Lilly and Company
Others
PBPK Models
DDI
CYPs
Citation Rankings
University / Institution:
# 5
Country:
# 14,567
Region:
# 15,917
World:
# 31,994
Citation
Total:
22,555
Last 6 Year:
4,677
Last 6 Year/Total:
0.207
i10 Index
Total:
174
Last 6 Year:
105
Last 6 Year/Total:
0.603
H-Index
Total:
76
Last 6 Year:
36
Last 6 Year/Total:
0.474
Ricardo Martinez
Ricardo Martinez
Eli Lilly and Company
Eli Lilly and Company
Medical and Health Sciences / Medical Oncology
Oncology
Genomics
Tailored Therapeutics
Citation Rankings
University / Institution:
# 6
Country:
# 17,872
Region:
# 19,621
World:
# 40,007
Citation
Total:
19,235
Last 6 Year:
4,579
Last 6 Year/Total:
0.238
i10 Index
Total:
36
Last 6 Year:
23
Last 6 Year/Total:
0.639
H-Index
Total:
28
Last 6 Year:
19
Last 6 Year/Total:
0.679
Jiye Shi
Jiye Shi
Eli Lilly and Company
Eli Lilly and Company
Engineering & Technology / Nanoscience and Nanotechnology
Drug Discovery
Informatics
Computational Chemistry
Biophysics
Nanotechnology
Citation Rankings
University / Institution:
# 7
Country:
# 21,097
Region:
# 23,191
World:
# 48,194
Citation
Total:
16,776
Last 6 Year:
11,173
Last 6 Year/Total:
0.666
i10 Index
Total:
204
Last 6 Year:
186
Last 6 Year/Total:
0.912
H-Index
Total:
65
Last 6 Year:
54
Last 6 Year/Total:
0.831
William Landschulz
William Landschulz
Eli Lilly and Company
Eli Lilly and Company
Others
Citation Rankings
University / Institution:
# 8
Country:
# 24,214
Region:
# 26,681
World:
# 56,143
Citation
Total:
14,964
Last 6 Year:
1,387
Last 6 Year/Total:
0.093
i10 Index
Total:
40
Last 6 Year:
23
Last 6 Year/Total:
0.575
H-Index
Total:
24
Last 6 Year:
16
Last 6 Year/Total:
0.667
JH Krege
JH Krege
Eli Lilly and Company
Eli Lilly and Company
Others
Osteoporosis
Migraine
Cardiovascular Disease
Drug Development
Citation Rankings
University / Institution:
# 9
Country:
# 24,602
Region:
# 27,117
World:
# 57,156
Citation
Total:
14,753
Last 6 Year:
3,706
Last 6 Year/Total:
0.251
i10 Index
Total:
98
Last 6 Year:
73
Last 6 Year/Total:
0.745
H-Index
Total:
55
Last 6 Year:
34
Last 6 Year/Total:
0.618
Eswar Krishnan
Eswar Krishnan
Eli Lilly and Company
Eli Lilly and Company
Others
Citation Rankings
University / Institution:
# 10
Country:
# 29,116
Region:
# 32,214
World:
# 69,260
Citation
Total:
12,731
Last 6 Year:
4,821
Last 6 Year/Total:
0.379
i10 Index
Total:
104
Last 6 Year:
83
Last 6 Year/Total:
0.798
H-Index
Total:
62
Last 6 Year:
39
Last 6 Year/Total:
0.629
Adscientificindex

Click for INSTITUTIONAL REGISTRATION and PREMIUM MEMBERSHIP advantages

Andrew C Adams
Andrew C Adams
Eli Lilly and Company
Eli Lilly and Company
Others
RNA
Oligonucleotides
Delivery of Novel Modalities
Virology
SARS-CoV-2
Citation Rankings
University / Institution:
# 11
Country:
# 30,388
Region:
# 33,630
World:
# 72,801
Citation
Total:
12,238
Last 6 Year:
8,305
Last 6 Year/Total:
0.679
i10 Index
Total:
62
Last 6 Year:
56
Last 6 Year/Total:
0.903
H-Index
Total:
39
Last 6 Year:
33
Last 6 Year/Total:
0.846
Michael O'Neill
Michael O'Neill
Eli Lilly and Company
Eli Lilly and Company
Others
Neurodegeneration
Neuroscience
Citation Rankings
University / Institution:
# 12
Country:
# 34,648
Region:
# 38,419
World:
# 84,495
Citation
Total:
10,811
Last 6 Year:
3,644
Last 6 Year/Total:
0.337
i10 Index
Total:
135
Last 6 Year:
74
Last 6 Year/Total:
0.548
H-Index
Total:
61
Last 6 Year:
32
Last 6 Year/Total:
0.525
Stéphane Epelbaum
Stéphane Epelbaum
Eli Lilly and Company
Eli Lilly and Company
Medical and Health Sciences / Neuroscience
Alzheimer's disease
Citation Rankings
University / Institution:
# 13
Country:
# 35,205
Region:
# 39,057
World:
# 86,093
Citation
Total:
10,645
Last 6 Year:
7,969
Last 6 Year/Total:
0.749
i10 Index
Total:
82
Last 6 Year:
79
Last 6 Year/Total:
0.963
H-Index
Total:
37
Last 6 Year:
35
Last 6 Year/Total:
0.946
Rebecca L Robinson
Rebecca L Robinson
Eli Lilly and Company
Eli Lilly and Company
Others
Health Outcomes
Real World Evidence
Pain
Citation Rankings
University / Institution:
# 14
Country:
# 37,618
Region:
# 41,805
World:
# 92,992
Citation
Total:
9,969
Last 6 Year:
3,368
Last 6 Year/Total:
0.338
i10 Index
Total:
52
Last 6 Year:
39
Last 6 Year/Total:
0.750
H-Index
Total:
34
Last 6 Year:
23
Last 6 Year/Total:
0.676
Sreekumar Pillai
Sreekumar Pillai
Eli Lilly and Company
Eli Lilly and Company
Natural Sciences / Molecular Biology & Genetics
Drug Discovery and Development
Precision Medicine
Digital Health
Genetics
Orphan diseases
Citation Rankings
University / Institution:
# 15
Country:
# 37,619
Region:
# 41,806
World:
# 92,993
Citation
Total:
9,969
Last 6 Year:
3,293
Last 6 Year/Total:
0.330
i10 Index
Total:
66
Last 6 Year:
49
Last 6 Year/Total:
0.742
H-Index
Total:
44
Last 6 Year:
28
Last 6 Year/Total:
0.636
Yaming Wang
Yaming Wang
Eli Lilly and Company
Eli Lilly and Company
Others
innate immunity
neuroimmunology
neurodegneration
pathagen/damage associated molecular patterns
host-pathogen interaction
Citation Rankings
University / Institution:
# 16
Country:
# 37,826
Region:
# 42,043
World:
# 93,621
Citation
Total:
9,910
Last 6 Year:
6,103
Last 6 Year/Total:
0.616
i10 Index
Total:
33
Last 6 Year:
29
Last 6 Year/Total:
0.879
H-Index
Total:
32
Last 6 Year:
24
Last 6 Year/Total:
0.750
Mark L Hartman
Mark L Hartman
Eli Lilly and Company
Eli Lilly and Company
Medical and Health Sciences / Endocrinology and Metabolism
Diabetes
endocrinology
fatty liver disease
Citation Rankings
University / Institution:
# 17
Country:
# 38,413
Region:
# 42,708
World:
# 95,311
Citation
Total:
9,758
Last 6 Year:
1,851
Last 6 Year/Total:
0.190
i10 Index
Total:
73
Last 6 Year:
39
Last 6 Year/Total:
0.534
H-Index
Total:
50
Last 6 Year:
22
Last 6 Year/Total:
0.440
Jonathan A Lee
Jonathan A Lee
Eli Lilly and Company
Eli Lilly and Company
Others
Citation Rankings
University / Institution:
# 18
Country:
# 38,418
Region:
# 42,713
World:
# 95,324
Citation
Total:
9,757
Last 6 Year:
2,425
Last 6 Year/Total:
0.249
i10 Index
Total:
141
Last 6 Year:
33
Last 6 Year/Total:
0.234
H-Index
Total:
48
Last 6 Year:
18
Last 6 Year/Total:
0.375
Bob Campbell
Bob Campbell
Eli Lilly and Company
Eli Lilly and Company
Medical and Health Sciences / Medical Oncology
oncology/I-O/autoimmune diseases
drug discovery
kinases
epigenetics
RNA modulation
Citation Rankings
University / Institution:
# 19
Country:
# 38,437
Region:
# 42,735
World:
# 95,383
Citation
Total:
9,752
Last 6 Year:
3,220
Last 6 Year/Total:
0.330
i10 Index
Total:
112
Last 6 Year:
39
Last 6 Year/Total:
0.348
H-Index
Total:
53
Last 6 Year:
26
Last 6 Year/Total:
0.491
Ian C Smith
Ian C Smith
Eli Lilly and Company
Eli Lilly and Company
Medical and Health Sciences / Medical Oncology
Oncology
Citation Rankings
University / Institution:
# 20
Country:
# 38,909
Region:
# 43,257
World:
# 96,734
Citation
Total:
9,634
Last 6 Year:
4,531
Last 6 Year/Total:
0.470
i10 Index
Total:
37
Last 6 Year:
20
Last 6 Year/Total:
0.541
H-Index
Total:
27
Last 6 Year:
16
Last 6 Year/Total:
0.593
Tony Zhang
Tony Zhang
Eli Lilly and Company
Eli Lilly and Company
Natural Sciences / Chemical Sciences
process chemistry
organic chemistry. pharmaceutical
green chemistry
catalysis
Citation Rankings
University / Institution:
# 21
Country:
# 39,159
Region:
# 43,542
World:
# 97,425
Citation
Total:
9,573
Last 6 Year:
3,992
Last 6 Year/Total:
0.417
i10 Index
Total:
143
Last 6 Year:
67
Last 6 Year/Total:
0.469
H-Index
Total:
47
Last 6 Year:
30
Last 6 Year/Total:
0.638
Prachi Sharma
Prachi Sharma
Eli Lilly and Company
Eli Lilly and Company
Medical and Health Sciences / Immunology
Immuno-Oncology
Citation Rankings
University / Institution:
# 22
Country:
# 39,305
Region:
# 43,697
World:
# 97,815
Citation
Total:
9,542
Last 6 Year:
5,069
Last 6 Year/Total:
0.531
i10 Index
Total:
207
Last 6 Year:
105
Last 6 Year/Total:
0.507
H-Index
Total:
45
Last 6 Year:
31
Last 6 Year/Total:
0.689
Philip Szekeres
Philip Szekeres
Eli Lilly and Company
Eli Lilly and Company
Medical and Health Sciences / Medical Oncology
Oncology
Neuroscience
Life Sciences
Citation Rankings
University / Institution:
# 23
Country:
# 42,997
Region:
# 47,863
World:
# 108,418
Citation
Total:
8,705
Last 6 Year:
2,578
Last 6 Year/Total:
0.296
i10 Index
Total:
31
Last 6 Year:
20
Last 6 Year/Total:
0.645
H-Index
Total:
26
Last 6 Year:
16
Last 6 Year/Total:
0.615
Francis Willard
Francis Willard
Eli Lilly and Company
Eli Lilly and Company
Medical and Health Sciences / Pharmacology
Drug Discovery
G-proteins
GPCRs
Receptors
Pharmacology
Citation Rankings
University / Institution:
# 24
Country:
# 48,200
Region:
# 53,705
World:
# 123,738
Citation
Total:
7,732
Last 6 Year:
2,593
Last 6 Year/Total:
0.335
i10 Index
Total:
81
Last 6 Year:
53
Last 6 Year/Total:
0.654
H-Index
Total:
48
Last 6 Year:
28
Last 6 Year/Total:
0.583
Richard E Higgs
Richard E Higgs
Eli Lilly and Company
Eli Lilly and Company
Natural Sciences / Mathematical Sciences
Statistics
Applied statistics in drug discovery
Translational research
Citation Rankings
University / Institution:
# 25
Country:
# 48,587
Region:
# 54,148
World:
# 124,954
Citation
Total:
7,667
Last 6 Year:
4,512
Last 6 Year/Total:
0.588
i10 Index
Total:
67
Last 6 Year:
37
Last 6 Year/Total:
0.552
H-Index
Total:
39
Last 6 Year:
23
Last 6 Year/Total:
0.590
Giacomo Ruotolo
Giacomo Ruotolo
Eli Lilly and Company
Eli Lilly and Company
Others
Lipoprotein Metabolism and Atherosclerosis
Citation Rankings
University / Institution:
# 26
Country:
# 49,418
Region:
# 55,074
World:
# 127,316
Citation
Total:
7,541
Last 6 Year:
2,461
Last 6 Year/Total:
0.326
i10 Index
Total:
74
Last 6 Year:
44
Last 6 Year/Total:
0.595
H-Index
Total:
43
Last 6 Year:
27
Last 6 Year/Total:
0.628
Scot J Matkovich
Scot J Matkovich
Eli Lilly and Company
Eli Lilly and Company
Others
Heart disease
inflammation
diabetes
noncoding RNAs
systems biology
Citation Rankings
University / Institution:
# 27
Country:
# 50,853
Region:
# 56,701
World:
# 131,688
Citation
Total:
7,313
Last 6 Year:
2,839
Last 6 Year/Total:
0.388
i10 Index
Total:
72
Last 6 Year:
57
Last 6 Year/Total:
0.792
H-Index
Total:
43
Last 6 Year:
32
Last 6 Year/Total:
0.744
Joel Raskin
Joel Raskin
Eli Lilly and Company
Eli Lilly and Company
Social Sciences / Psychology
psychopharmamcology
Citation Rankings
University / Institution:
# 28
Country:
# 51,846
Region:
# 57,821
World:
# 134,818
Citation
Total:
7,153
Last 6 Year:
2,220
Last 6 Year/Total:
0.310
i10 Index
Total:
73
Last 6 Year:
38
Last 6 Year/Total:
0.521
H-Index
Total:
42
Last 6 Year:
22
Last 6 Year/Total:
0.524
David H Adams
David H Adams
Eli Lilly and Company
Eli Lilly and Company
Others
Citation Rankings
University / Institution:
# 29
Country:
# 52,054
Region:
# 58,059
World:
# 135,464
Citation
Total:
7,121
Last 6 Year:
3,525
Last 6 Year/Total:
0.495
i10 Index
Total:
86
Last 6 Year:
49
Last 6 Year/Total:
0.570
H-Index
Total:
40
Last 6 Year:
26
Last 6 Year/Total:
0.650
Stephanie De Bono
Stephanie De Bono
Eli Lilly and Company
Eli Lilly and Company
Medical and Health Sciences / Rheumatology
rheumatology
jak inhibitors
COVID
hyperinflammatory states
dermatology
Citation Rankings
University / Institution:
# 30
Country:
# 52,257
Region:
# 58,279
World:
# 136,035
Citation
Total:
7,093
Last 6 Year:
6,040
Last 6 Year/Total:
0.852
i10 Index
Total:
33
Last 6 Year:
27
Last 6 Year/Total:
0.818
H-Index
Total:
26
Last 6 Year:
24
Last 6 Year/Total:
0.923
Adscientificindex

A New and Different Feature!!!! University Subject Rankings in 12 subjects:

Ranking and analysis of universities by subject in 12 fields such as health, engineering, natural sciences, education, business, economics, social sciences, etc.
Joe Johnston
Joe Johnston
Eli Lilly and Company
Eli Lilly and Company
Medical and Health Sciences / Pediatrics and Child Health
Health outcomes
pediatrics
epidemiology
Citation Rankings
University / Institution:
# 31
Country:
# 53,190
Region:
# 59,335
World:
# 138,988
Citation
Total:
6,952
Last 6 Year:
3,036
Last 6 Year/Total:
0.437
i10 Index
Total:
67
Last 6 Year:
41
Last 6 Year/Total:
0.612
H-Index
Total:
34
Last 6 Year:
21
Last 6 Year/Total:
0.618
José Antonio Sacristán
José Antonio Sacristán
Eli Lilly and Company
Eli Lilly and Company
Others
Clinical research
patients
methodology
effectiveness
cost-effectiveness
Citation Rankings
University / Institution:
# 32
Country:
# 56,193
Region:
# 62,747
World:
# 148,240
Citation
Total:
6,540
Last 6 Year:
2,213
Last 6 Year/Total:
0.338
i10 Index
Total:
100
Last 6 Year:
38
Last 6 Year/Total:
0.380
H-Index
Total:
41
Last 6 Year:
20
Last 6 Year/Total:
0.488
David Cox
David Cox
Eli Lilly and Company
Eli Lilly and Company
Others
Citation Rankings
University / Institution:
# 33
Country:
# 57,472
Region:
# 64,197
World:
# 152,238
Citation
Total:
6,370
Last 6 Year:
853
Last 6 Year/Total:
0.134
i10 Index
Total:
50
Last 6 Year:
22
Last 6 Year/Total:
0.440
H-Index
Total:
32
Last 6 Year:
14
Last 6 Year/Total:
0.438
J Michael Sauder
J Michael Sauder
Eli Lilly and Company
Eli Lilly and Company
Natural Sciences / Biological Science
structural biology
computational biology
structural bioinformatics
biophysics
Citation Rankings
University / Institution:
# 34
Country:
# 58,221
Region:
# 65,046
World:
# 154,521
Citation
Total:
6,281
Last 6 Year:
1,838
Last 6 Year/Total:
0.293
i10 Index
Total:
56
Last 6 Year:
27
Last 6 Year/Total:
0.482
H-Index
Total:
33
Last 6 Year:
18
Last 6 Year/Total:
0.545
Louis F Stancato
Louis F Stancato
Eli Lilly and Company
Eli Lilly and Company
Others
Cancer
Citation Rankings
University / Institution:
# 35
Country:
# 59,946
Region:
# 66,982
World:
# 159,989
Citation
Total:
6,071
Last 6 Year:
1,575
Last 6 Year/Total:
0.259
i10 Index
Total:
64
Last 6 Year:
37
Last 6 Year/Total:
0.578
H-Index
Total:
42
Last 6 Year:
23
Last 6 Year/Total:
0.548
Xiaoyu Zhang
Xiaoyu Zhang
Eli Lilly and Company
Eli Lilly and Company
Engineering & Technology / Metallurgical & Materials Engineering
Materials Science and Engineering
Analytical
Formulation
Process
Automation
Citation Rankings
University / Institution:
# 36
Country:
# 60,446
Region:
# 67,543
World:
# 161,598
Citation
Total:
6,011
Last 6 Year:
1,055
Last 6 Year/Total:
0.176
i10 Index
Total:
25
Last 6 Year:
18
Last 6 Year/Total:
0.720
H-Index
Total:
20
Last 6 Year:
16
Last 6 Year/Total:
0.800
James W Perfield Ii
James W Perfield Ii
Eli Lilly and Company
Eli Lilly and Company
Others
Citation Rankings
University / Institution:
# 37
Country:
# 60,965
Region:
# 68,124
World:
# 163,313
Citation
Total:
5,947
Last 6 Year:
1,907
Last 6 Year/Total:
0.321
i10 Index
Total:
53
Last 6 Year:
39
Last 6 Year/Total:
0.736
H-Index
Total:
35
Last 6 Year:
23
Last 6 Year/Total:
0.657
Michal Vieth
Michal Vieth
Eli Lilly and Company
Eli Lilly and Company
Natural Sciences / Chemical Sciences
cancer cure and business
power of brain
VR and AI
extreme sports psychology and sociology
Citation Rankings
University / Institution:
# 38
Country:
# 63,983
Region:
# 71,515
World:
# 172,916
Citation
Total:
5,615
Last 6 Year:
1,470
Last 6 Year/Total:
0.262
i10 Index
Total:
47
Last 6 Year:
25
Last 6 Year/Total:
0.532
H-Index
Total:
30
Last 6 Year:
17
Last 6 Year/Total:
0.567
Sudhakar Reddy Chintharlapalli
Sudhakar Reddy Chintharlapalli
Eli Lilly and Company
Eli Lilly and Company
Medical and Health Sciences / Immunology
Immunooncology
Myeloid Biology
Angiogenesis
Oncology
Cancer Therapeutics
Citation Rankings
University / Institution:
# 39
Country:
# 64,485
Region:
# 72,067
World:
# 174,405
Citation
Total:
5,566
Last 6 Year:
2,005
Last 6 Year/Total:
0.360
i10 Index
Total:
55
Last 6 Year:
39
Last 6 Year/Total:
0.709
H-Index
Total:
35
Last 6 Year:
21
Last 6 Year/Total:
0.600
Imre Pavo
Imre Pavo
Eli Lilly and Company
Eli Lilly and Company
Others
diabetes
cardiovascular diseases
osteoporosis
Citation Rankings
University / Institution:
# 40
Country:
# 64,859
Region:
# 72,486
World:
# 175,719
Citation
Total:
5,526
Last 6 Year:
2,193
Last 6 Year/Total:
0.397
i10 Index
Total:
85
Last 6 Year:
49
Last 6 Year/Total:
0.576
H-Index
Total:
38
Last 6 Year:
24
Last 6 Year/Total:
0.632
Leonard C Glass
Leonard C Glass
Eli Lilly and Company
Eli Lilly and Company
Others
diabetes
Citation Rankings
University / Institution:
# 41
Country:
# 64,959
Region:
# 72,596
World:
# 176,003
Citation
Total:
5,517
Last 6 Year:
1,249
Last 6 Year/Total:
0.226
i10 Index
Total:
23
Last 6 Year:
14
Last 6 Year/Total:
0.609
H-Index
Total:
20
Last 6 Year:
13
Last 6 Year/Total:
0.650
Klaus Gottlieb
Klaus Gottlieb
Eli Lilly and Company
Eli Lilly and Company
Others
Clinical Trials
Inflammatory Bowel Disease
Citation Rankings
University / Institution:
# 42
Country:
# 66,103
Region:
# 73,905
World:
# 179,698
Citation
Total:
5,400
Last 6 Year:
1,656
Last 6 Year/Total:
0.307
i10 Index
Total:
66
Last 6 Year:
36
Last 6 Year/Total:
0.545
H-Index
Total:
37
Last 6 Year:
23
Last 6 Year/Total:
0.622
Zvonko Milicevic
Zvonko Milicevic
Eli Lilly and Company
Eli Lilly and Company
Others
Diabetes
Citation Rankings
University / Institution:
# 43
Country:
# 66,466
Region:
# 74,307
World:
# 180,893
Citation
Total:
5,362
Last 6 Year:
2,987
Last 6 Year/Total:
0.557
i10 Index
Total:
67
Last 6 Year:
33
Last 6 Year/Total:
0.493
H-Index
Total:
33
Last 6 Year:
26
Last 6 Year/Total:
0.788
Zhuo Fang
Zhuo Fang
Eli Lilly and Company
Eli Lilly and Company
Natural Sciences / Molecular Biology & Genetics
Bioinformatics
Genomics
Citation Rankings
University / Institution:
# 44
Country:
# 66,874
Region:
# 74,773
World:
# 182,210
Citation
Total:
5,323
Last 6 Year:
1,268
Last 6 Year/Total:
0.238
i10 Index
Total:
10
Last 6 Year:
6
Last 6 Year/Total:
0.600
H-Index
Total:
10
Last 6 Year:
7
Last 6 Year/Total:
0.700
Mathijs C Bunck
Mathijs C Bunck
Eli Lilly and Company
Eli Lilly and Company
Others
Nutrient-Stimulated Hormone
Obesity
CVD
NASH
Citation Rankings
University / Institution:
# 45
Country:
# 67,968
Region:
# 76,008
World:
# 185,857
Citation
Total:
5,215
Last 6 Year:
2,376
Last 6 Year/Total:
0.456
i10 Index
Total:
30
Last 6 Year:
26
Last 6 Year/Total:
0.867
H-Index
Total:
25
Last 6 Year:
19
Last 6 Year/Total:
0.760
Aaron Schacht
Aaron Schacht
Eli Lilly and Company
Eli Lilly and Company
Medical and Health Sciences / Pharmacy & Pharmaceutical Sciences
Pharmaceuticals
Biotechnoloyg
Citation Rankings
University / Institution:
# 46
Country:
# 71,348
Region:
# 79,843
World:
# 196,689
Citation
Total:
4,918
Last 6 Year:
1,874
Last 6 Year/Total:
0.381
i10 Index
Total:
15
Last 6 Year:
2
Last 6 Year/Total:
0.133
H-Index
Total:
13
Last 6 Year:
3
Last 6 Year/Total:
0.231
Gopuraja Dharmalingam
Gopuraja Dharmalingam
Eli Lilly and Company
Eli Lilly and Company
Natural Sciences / Molecular Biology & Genetics
Genetics
Bioinformatics
Data Science and Drug Discovery Informatics
Citation Rankings
University / Institution:
# 47
Country:
# 73,412
Region:
# 82,192
World:
# 203,650
Citation
Total:
4,742
Last 6 Year:
3,346
Last 6 Year/Total:
0.706
i10 Index
Total:
28
Last 6 Year:
25
Last 6 Year/Total:
0.893
H-Index
Total:
22
Last 6 Year:
18
Last 6 Year/Total:
0.818
Wei Shen
Wei Shen
Eli Lilly and Company
Eli Lilly and Company
Natural Sciences / Mathematical Sciences
Statistics
clinical trials
health outcomes research
Bayesian methods
Citation Rankings
University / Institution:
# 48
Country:
# 75,325
Region:
# 84,374
World:
# 210,030
Citation
Total:
4,592
Last 6 Year:
937
Last 6 Year/Total:
0.204
i10 Index
Total:
40
Last 6 Year:
22
Last 6 Year/Total:
0.550
H-Index
Total:
31
Last 6 Year:
18
Last 6 Year/Total:
0.581
Yvonne Monique Kobayashi
Yvonne Monique Kobayashi
Eli Lilly and Company
Eli Lilly and Company
Others
Muscle & Metabolism
Citation Rankings
University / Institution:
# 49
Country:
# 77,249
Region:
# 86,538
World:
# 216,469
Citation
Total:
4,447
Last 6 Year:
776
Last 6 Year/Total:
0.174
i10 Index
Total:
24
Last 6 Year:
16
Last 6 Year/Total:
0.667
H-Index
Total:
23
Last 6 Year:
13
Last 6 Year/Total:
0.565
Prashant Desai
Prashant Desai
Eli Lilly and Company
Eli Lilly and Company
Others
Drug discovery
Citation Rankings
University / Institution:
# 50
Country:
# 81,618
Region:
# 91,518
World:
# 231,305
Citation
Total:
4,138
Last 6 Year:
1,263
Last 6 Year/Total:
0.305
i10 Index
Total:
49
Last 6 Year:
31
Last 6 Year/Total:
0.633
H-Index
Total:
29
Last 6 Year:
19
Last 6 Year/Total:
0.655
AD Scientific Index - Scientist Citation Rankings - 2024 CITATION H INDEX i10 INDEX
University Country Region World Name Country University / Institution Subject Total Last 6 Year Last 6 year/total Total Last 6 year Last 6 year/total Total Last 6 year Last 6 year/total
1 2004 2162 4147
David A CollierDavid A Collier i
United States Eli Lilly and Company Eli Lilly and Company Social Sciences / Psychology

psychosis | neurodegeneration | bioinformatics | genomics | drug development |

80727 27588 0.342 122 62 0.508 436 247 0.567
2 7540 8171 15841
Martin CitronMartin Citron
United States Eli Lilly and Company Eli Lilly and Company Others

Alzheimer's disease | Neurodegeneration | Drug discovery |

35642 6111 0.171 60 37 0.617 82 61 0.744
3 11797 12842 25501
David R FerryDavid R Ferry
United States Eli Lilly and Company Eli Lilly and Company Others

GI cancer | translational research | lung cancer | phase 1 trials |

26276 8585 0.327 73 40 0.548 175 84 0.480
4 12708 13843 27592
Christian C FelderChristian C Felder
United States Eli Lilly and Company Eli Lilly and Company Medical and Health Sciences / Neuroscience

Neuroscience & Drug Discovery |

24931 4992 0.200 75 33 0.440 141 86 0.610
5 14567 15917 31994
Stephen HallStephen Hall
United States Eli Lilly and Company Eli Lilly and Company Others

PBPK Models | DDI | CYPs |

22555 4677 0.207 76 36 0.474 174 105 0.603
6 17872 19621 40007
Ricardo MartinezRicardo Martinez
United States Eli Lilly and Company Eli Lilly and Company Medical and Health Sciences / Medical Oncology

Oncology | Genomics | Tailored Therapeutics |

19235 4579 0.238 28 19 0.679 36 23 0.639
7 21097 23191 48194
Jiye ShiJiye Shi
United States Eli Lilly and Company Eli Lilly and Company Engineering & Technology / Nanoscience and Nanotechnology

Drug Discovery | Informatics | Computational Chemistry | Biophysics | Nanotechnology |

16776 11173 0.666 65 54 0.831 204 186 0.912
8 24214 26681 56143
William LandschulzWilliam Landschulz
United States Eli Lilly and Company Eli Lilly and Company Others

14964 1387 0.093 24 16 0.667 40 23 0.575
9 24602 27117 57156
JH KregeJH Krege
United States Eli Lilly and Company Eli Lilly and Company Others

Osteoporosis | Migraine | Cardiovascular Disease | Drug Development |

14753 3706 0.251 55 34 0.618 98 73 0.745
10 29116 32214 69260
Eswar KrishnanEswar Krishnan
United States Eli Lilly and Company Eli Lilly and Company Others

12731 4821 0.379 62 39 0.629 104 83 0.798
Adscientificindex

Click for INSTITUTIONAL REGISTRATION and PREMIUM MEMBERSHIP advantages
11 30388 33630 72801
Andrew C AdamsAndrew C Adams
United States Eli Lilly and Company Eli Lilly and Company Others

RNA | Oligonucleotides | Delivery of Novel Modalities | Virology | SARS-CoV-2 |

12238 8305 0.679 39 33 0.846 62 56 0.903
12 34648 38419 84495
Michael O'NeillMichael O'Neill
United States Eli Lilly and Company Eli Lilly and Company Others

Neurodegeneration | Neuroscience |

10811 3644 0.337 61 32 0.525 135 74 0.548
13 35205 39057 86093
Stéphane EpelbaumStéphane Epelbaum
United States Eli Lilly and Company Eli Lilly and Company Medical and Health Sciences / Neuroscience

Alzheimer's disease |

10645 7969 0.749 37 35 0.946 82 79 0.963
14 37618 41805 92992
Rebecca L RobinsonRebecca L Robinson
United States Eli Lilly and Company Eli Lilly and Company Others

Health Outcomes | Real World Evidence | Pain |

9969 3368 0.338 34 23 0.676 52 39 0.750
15 37619 41806 92993
Sreekumar PillaiSreekumar Pillai
United States Eli Lilly and Company Eli Lilly and Company Natural Sciences / Molecular Biology & Genetics

Drug Discovery and Development | Precision Medicine | Digital Health | Genetics | Orphan diseases |

9969 3293 0.330 44 28 0.636 66 49 0.742
16 37826 42043 93621
Yaming WangYaming Wang
United States Eli Lilly and Company Eli Lilly and Company Others

innate immunity | neuroimmunology | neurodegneration | pathagen/damage associated molecular patterns | host-pathogen interaction |

9910 6103 0.616 32 24 0.750 33 29 0.879
17 38413 42708 95311
Mark L HartmanMark L Hartman
United States Eli Lilly and Company Eli Lilly and Company Medical and Health Sciences / Endocrinology and Metabolism

Diabetes | endocrinology | fatty liver disease |

9758 1851 0.190 50 22 0.440 73 39 0.534
18 38418 42713 95324
Jonathan A LeeJonathan A Lee
United States Eli Lilly and Company Eli Lilly and Company Others

9757 2425 0.249 48 18 0.375 141 33 0.234
19 38437 42735 95383
Bob CampbellBob Campbell
United States Eli Lilly and Company Eli Lilly and Company Medical and Health Sciences / Medical Oncology

oncology/I-O/autoimmune diseases | drug discovery | kinases | epigenetics | RNA modulation |

9752 3220 0.330 53 26 0.491 112 39 0.348
20 38909 43257 96734
Ian C SmithIan C Smith
United States Eli Lilly and Company Eli Lilly and Company Medical and Health Sciences / Medical Oncology

Oncology |

9634 4531 0.470 27 16 0.593 37 20 0.541
21 39159 43542 97425
Tony ZhangTony Zhang
United States Eli Lilly and Company Eli Lilly and Company Natural Sciences / Chemical Sciences

process chemistry | organic chemistry. pharmaceutical | green chemistry | catalysis |

9573 3992 0.417 47 30 0.638 143 67 0.469
22 39305 43697 97815
Prachi SharmaPrachi Sharma
United States Eli Lilly and Company Eli Lilly and Company Medical and Health Sciences / Immunology

Immuno-Oncology |

9542 5069 0.531 45 31 0.689 207 105 0.507
23 42997 47863 108418
Philip SzekeresPhilip Szekeres
United States Eli Lilly and Company Eli Lilly and Company Medical and Health Sciences / Medical Oncology

Oncology | Neuroscience | Life Sciences |

8705 2578 0.296 26 16 0.615 31 20 0.645
24 48200 53705 123738
Francis WillardFrancis Willard
United States Eli Lilly and Company Eli Lilly and Company Medical and Health Sciences / Pharmacology

Drug Discovery | G-proteins | GPCRs | Receptors | Pharmacology |

7732 2593 0.335 48 28 0.583 81 53 0.654
25 48587 54148 124954
Richard E HiggsRichard E Higgs
United States Eli Lilly and Company Eli Lilly and Company Natural Sciences / Mathematical Sciences

Statistics | Applied statistics in drug discovery | Translational research |

7667 4512 0.588 39 23 0.590 67 37 0.552
26 49418 55074 127316
Giacomo RuotoloGiacomo Ruotolo
United States Eli Lilly and Company Eli Lilly and Company Others

Lipoprotein Metabolism and Atherosclerosis |

7541 2461 0.326 43 27 0.628 74 44 0.595
27 50853 56701 131688
Scot J MatkovichScot J Matkovich
United States Eli Lilly and Company Eli Lilly and Company Others

Heart disease | inflammation | diabetes | noncoding RNAs | systems biology |

7313 2839 0.388 43 32 0.744 72 57 0.792
28 51846 57821 134818
Joel RaskinJoel Raskin
United States Eli Lilly and Company Eli Lilly and Company Social Sciences / Psychology

psychopharmamcology |

7153 2220 0.310 42 22 0.524 73 38 0.521
29 52054 58059 135464
David H AdamsDavid H Adams
United States Eli Lilly and Company Eli Lilly and Company Others

7121 3525 0.495 40 26 0.650 86 49 0.570
30 52257 58279 136035
Stephanie De BonoStephanie De Bono
United States Eli Lilly and Company Eli Lilly and Company Medical and Health Sciences / Rheumatology

rheumatology | jak inhibitors | COVID | hyperinflammatory states | dermatology |

7093 6040 0.852 26 24 0.923 33 27 0.818
Adscientificindex

A New and Different Feature!!!! University Subject Rankings in 12 subjects:

Ranking and analysis of universities by subject in 12 fields such as health, engineering, natural sciences, education, business, economics, social sciences, etc.
31 53190 59335 138988
Joe JohnstonJoe Johnston
United States Eli Lilly and Company Eli Lilly and Company Medical and Health Sciences / Pediatrics and Child Health

Health outcomes | pediatrics | epidemiology |

6952 3036 0.437 34 21 0.618 67 41 0.612
32 56193 62747 148240
José Antonio SacristánJosé Antonio Sacristán
United States Eli Lilly and Company Eli Lilly and Company Others

Clinical research | patients | methodology | effectiveness | cost-effectiveness |

6540 2213 0.338 41 20 0.488 100 38 0.380
33 57472 64197 152238
David CoxDavid Cox
United States Eli Lilly and Company Eli Lilly and Company Others

6370 853 0.134 32 14 0.438 50 22 0.440
34 58221 65046 154521
J Michael SauderJ Michael Sauder
United States Eli Lilly and Company Eli Lilly and Company Natural Sciences / Biological Science

structural biology | computational biology | structural bioinformatics | biophysics |

6281 1838 0.293 33 18 0.545 56 27 0.482
35 59946 66982 159989
Louis F StancatoLouis F Stancato
United States Eli Lilly and Company Eli Lilly and Company Others

Cancer |

6071 1575 0.259 42 23 0.548 64 37 0.578
36 60446 67543 161598
Xiaoyu ZhangXiaoyu Zhang
United States Eli Lilly and Company Eli Lilly and Company Engineering & Technology / Metallurgical & Materials Engineering

Materials Science and Engineering | Analytical | Formulation | Process | Automation |

6011 1055 0.176 20 16 0.800 25 18 0.720
37 60965 68124 163313
James W Perfield IiJames W Perfield Ii
United States Eli Lilly and Company Eli Lilly and Company Others

5947 1907 0.321 35 23 0.657 53 39 0.736
38 63983 71515 172916
Michal ViethMichal Vieth
United States Eli Lilly and Company Eli Lilly and Company Natural Sciences / Chemical Sciences

cancer cure and business | power of brain | VR and AI | extreme sports psychology and sociology |

5615 1470 0.262 30 17 0.567 47 25 0.532
39 64485 72067 174405
Sudhakar Reddy ChintharlapalliSudhakar Reddy Chintharlapalli
United States Eli Lilly and Company Eli Lilly and Company Medical and Health Sciences / Immunology

Immunooncology | Myeloid Biology | Angiogenesis | Oncology | Cancer Therapeutics |

5566 2005 0.360 35 21 0.600 55 39 0.709
40 64859 72486 175719
Imre PavoImre Pavo
United States Eli Lilly and Company Eli Lilly and Company Others

diabetes | cardiovascular diseases | osteoporosis |

5526 2193 0.397 38 24 0.632 85 49 0.576
41 64959 72596 176003
Leonard C GlassLeonard C Glass
United States Eli Lilly and Company Eli Lilly and Company Others

diabetes |

5517 1249 0.226 20 13 0.650 23 14 0.609
42 66103 73905 179698
Klaus GottliebKlaus Gottlieb
United States Eli Lilly and Company Eli Lilly and Company Others

Clinical Trials | Inflammatory Bowel Disease |

5400 1656 0.307 37 23 0.622 66 36 0.545
43 66466 74307 180893
Zvonko MilicevicZvonko Milicevic
United States Eli Lilly and Company Eli Lilly and Company Others

Diabetes |

5362 2987 0.557 33 26 0.788 67 33 0.493
44 66874 74773 182210
Zhuo FangZhuo Fang
United States Eli Lilly and Company Eli Lilly and Company Natural Sciences / Molecular Biology & Genetics

Bioinformatics | Genomics |

5323 1268 0.238 10 7 0.700 10 6 0.600
45 67968 76008 185857
Mathijs C BunckMathijs C Bunck
United States Eli Lilly and Company Eli Lilly and Company Others

Nutrient-Stimulated Hormone | Obesity | CVD | NASH |

5215 2376 0.456 25 19 0.760 30 26 0.867
46 71348 79843 196689
Aaron SchachtAaron Schacht
United States Eli Lilly and Company Eli Lilly and Company Medical and Health Sciences / Pharmacy & Pharmaceutical Sciences

Pharmaceuticals | Biotechnoloyg |

4918 1874 0.381 13 3 0.231 15 2 0.133
47 73412 82192 203650
Gopuraja DharmalingamGopuraja Dharmalingam
United States Eli Lilly and Company Eli Lilly and Company Natural Sciences / Molecular Biology & Genetics

Genetics | Bioinformatics | Data Science and Drug Discovery Informatics |

4742 3346 0.706 22 18 0.818 28 25 0.893
48 75325 84374 210030
Wei ShenWei Shen
United States Eli Lilly and Company Eli Lilly and Company Natural Sciences / Mathematical Sciences

Statistics | clinical trials | health outcomes research | Bayesian methods |

4592 937 0.204 31 18 0.581 40 22 0.550
49 77249 86538 216469
Yvonne Monique KobayashiYvonne Monique Kobayashi
United States Eli Lilly and Company Eli Lilly and Company Others

Muscle & Metabolism |

4447 776 0.174 23 13 0.565 24 16 0.667
50 81618 91518 231305
Prashant DesaiPrashant Desai
United States Eli Lilly and Company Eli Lilly and Company Others

Drug discovery |

4138 1263 0.305 29 19 0.655 49 31 0.633